• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

L-dopa long-term treatment in Parkinson's disease: age-related side effects.

作者信息

Pederzoli M, Girotti F, Scigliano G, Aiello G, Carella F, Caraceni T

出版信息

Neurology. 1983 Nov;33(11):1518-22. doi: 10.1212/wnl.33.11.1518.

DOI:10.1212/wnl.33.11.1518
PMID:6415513
Abstract

One hundred ninety L-dopa-treated parkinsonian patients have been studied according to the age at onset and to age at last examination. The frequency of major mental disturbances was significantly higher in patients older than 60 years, whereas abnormal involuntary movements and on-off phenomenon were more frequent in patients with onset before age 60. The association of normal aging and of Parkinson's disease may be responsible for the prevalence of mental disease in older patients.

摘要

相似文献

1
L-dopa long-term treatment in Parkinson's disease: age-related side effects.
Neurology. 1983 Nov;33(11):1518-22. doi: 10.1212/wnl.33.11.1518.
2
Dilemma in the treatment of Parkinson's disease with L-dopa.左旋多巴治疗帕金森病的困境。
Eur Neurol. 1994;34 Suppl 3:17-9. doi: 10.1159/000119537.
3
Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis.急性左旋多巴激发试验对持续长期左旋多巴反应进行临床预测的准确性作为特发性帕金森病诊断的主要标准。
Mov Disord. 2002 Jul;17(4):795-8. doi: 10.1002/mds.10123.
4
Does levodopa aggravate Parkinson's disease?左旋多巴会加重帕金森病吗?
Neurology. 1988 Sep;38(9):1410-6. doi: 10.1212/wnl.38.9.1410.
5
Patterns of clinical response and plasma dopa levels in Parkinson's disease.帕金森病的临床反应模式与血浆多巴水平
Neurology. 1975 Feb;25(2):177-83. doi: 10.1212/wnl.25.2.177.
6
Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patients.帕金森病患者中,玛伐谷氨酸(AFQ056)与增加左旋多巴剂量联合使用。
Int J Neurosci. 2016;126(1):20-4. doi: 10.3109/00207454.2013.841685. Epub 2015 Aug 18.
7
Opioids and motor complications in Parkinson's disease.帕金森病中的阿片类药物与运动并发症
Trends Pharmacol Sci. 2006 Oct;27(10):512-7. doi: 10.1016/j.tips.2006.08.002. Epub 2006 Sep 5.
8
Treatment strategies in Parkinson's disease after a quarter century experiences with L-DOPA therapy.在经历四分之一个世纪的左旋多巴治疗后帕金森病的治疗策略。
J Neural Transm Suppl. 1995;46:381-9.
9
Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease.帕金森病中左旋多巴诱导的运动障碍和开-关现象发展的预测因素。
Mov Disord. 2013 Jul;28(8):1064-71. doi: 10.1002/mds.25364. Epub 2013 Apr 29.
10
[Central side effects of long-term treatment of Parkinson disease with levodopa preparations].[左旋多巴制剂长期治疗帕金森病的中枢性副作用]
Neurol Neurochir Pol. 1991 Jul-Aug;25(4):449-54.

引用本文的文献

1
Substantia Nigra Echogenicity Signal Correlated with Clinical Features in Patients with Parkinson's Disease in Xinjiang.新疆帕金森病患者黑质回声信号与临床特征的相关性
Parkinsons Dis. 2023 Jun 1;2023:8867546. doi: 10.1155/2023/8867546. eCollection 2023.
2
Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?药物诱发的帕金森病运动障碍。临床管理的成功是否应取决于运动障碍幅度的改善,而不是运动障碍的改善?
BMC Med. 2013 Mar 20;11:76. doi: 10.1186/1741-7015-11-76.
3
A comprehensive model of health-related quality of life in Parkinson's disease.
帕金森病健康相关生活质量的综合模型。
J Neurol. 2008 Oct;255(10):1580-7. doi: 10.1007/s00415-008-0994-4. Epub 2008 Sep 24.
4
Cognitive impairment in Parkinson's disease.帕金森病中的认知障碍。
J Neurol Neurosurg Psychiatry. 2007 Nov;78(11):1182-7. doi: 10.1136/jnnp.2006.112367. Epub 2007 Apr 18.
5
The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years.悉尼帕金森病多中心研究:10年病程及死亡率
J Neurol Neurosurg Psychiatry. 1999 Sep;67(3):300-7. doi: 10.1136/jnnp.67.3.300.
6
Age influences magnitude but not duration of response to levodopa.年龄影响对左旋多巴反应的程度,但不影响反应的持续时间。
J Neurol Neurosurg Psychiatry. 1993 Jan;56(1):65-8. doi: 10.1136/jnnp.56.1.65.
7
Levodopa-induced dyskinesia: clinical observations.左旋多巴诱发的运动障碍:临床观察
J Neurol. 1985;232(1):29-31. doi: 10.1007/BF00314037.
8
The effect of age of disease onset on neuropsychological performance in Parkinson's disease.疾病发病年龄对帕金森病神经心理学表现的影响。
J Neurol Neurosurg Psychiatry. 1988 Feb;51(2):244-9. doi: 10.1136/jnnp.51.2.244.
9
Hallucinations in Parkinson disease: neuropsychological study.帕金森病中的幻觉:神经心理学研究
Ital J Neurol Sci. 1990 Aug;11(4):373-9. doi: 10.1007/BF02335940.